TipRanks
Advertisement
Advertisement

ATYR Stock Latest News

Why is aTyr Pharma Stock (ATYR) Down 7% Today?
Market NewsWhy is aTyr Pharma Stock (ATYR) Down 7% Today?
12h ago
ATYR
aTyr Pharma Aligns with FDA on Efzofitimod Phase 3
PremiumCompany Announcements
aTyr Pharma Aligns with FDA on Efzofitimod Phase 3
14h ago
8K
ATYR
aTyr Pharma announces alignment with FDA on Phase 3 study of efzofitimod
PremiumThe Fly
aTyr Pharma announces alignment with FDA on Phase 3 study of efzofitimod
18h ago
ATYR
aTyr Pharma reports Q2 EPS (11c), consensus (13c)
PremiumThe Fly
aTyr Pharma reports Q2 EPS (11c), consensus (13c)
2M ago
ATYR
aTyr Pharma announces restructuring, will lay off roughly 60% of workforce
PremiumThe Fly
aTyr Pharma announces restructuring, will lay off roughly 60% of workforce
2M ago
ATYR
aTyr Pharma Regains Global Rights to Efzofitimod
PremiumCompany AnnouncementsaTyr Pharma Regains Global Rights to Efzofitimod
2M ago
8K
ATYR
aTyr Pharma Lawsuit: Company Asks Court to Dismiss Investor Securities Claims 
Premium
Class Action
aTyr Pharma Lawsuit: Company Asks Court to Dismiss Investor Securities Claims 
2M ago
ATYR
Joseph Pantginis Reiterates Hold as Efzofitimod Shifts to Restrictive Lung Phenotype After Mixed Phase 3 EFZO-FIT Results
Premium
Ratings
Joseph Pantginis Reiterates Hold as Efzofitimod Shifts to Restrictive Lung Phenotype After Mixed Phase 3 EFZO-FIT Results
2M ago
ATYR
aTyr Pharma Granted Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
aTyr Pharma Granted Nasdaq Extension to Regain Compliance
4M ago
8K
ATYR
Phase 3 Efzofitimod Readout Nears: What ATYR Investors Should Watch in Pulmonary Sarcoidosis
PremiumCompany Announcements
Phase 3 Efzofitimod Readout Nears: What ATYR Investors Should Watch in Pulmonary Sarcoidosis
4M ago
ATYR
aTyr Pharma Refines Efzofitimod Strategy After Phase 2 Data
PremiumCompany Announcements
aTyr Pharma Refines Efzofitimod Strategy After Phase 2 Data
4M ago
8K
ATYR
aTyr Pharma upgraded to Buy from Hold at Freedom Broker
PremiumThe Fly
aTyr Pharma upgraded to Buy from Hold at Freedom Broker
4M ago
ATYR
aTyr Pharma Inc options imply 30.5% move in share price post-earnings
PremiumThe FlyaTyr Pharma Inc options imply 30.5% move in share price post-earnings
4M ago
ATYR
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
Premium
The Fly
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
4M ago
BX
DLO
aTyr Pharma reports Q1 EPS (11c), consensus (15c)
Premium
The Fly
aTyr Pharma reports Q1 EPS (11c), consensus (15c)
4M ago
ATYR
Boris Peaker Reiterates Hold as Constructive FDA Pathway Is Offset by Long Timelines and Funding Overhang for Efzofitimod Sarcoidosis Program
PremiumRatings
Boris Peaker Reiterates Hold as Constructive FDA Pathway Is Offset by Long Timelines and Funding Overhang for Efzofitimod Sarcoidosis Program
5M ago
ATYR
Joseph Pantginis Reiterates Hold Rating as FDA Feedback Refocuses Phase 3 Trial Despite Prior Endpoint Miss
PremiumRatings
Joseph Pantginis Reiterates Hold Rating as FDA Feedback Refocuses Phase 3 Trial Despite Prior Endpoint Miss
5M ago
ATYR
aTyr Pharma provides regulatory update on efzofitimod following Type C meeting
PremiumThe Fly
aTyr Pharma provides regulatory update on efzofitimod following Type C meeting
5M ago
ATYR
aTyr Pharma Announces New Phase 3 Sarcoidosis Trial
PremiumCompany Announcements
aTyr Pharma Announces New Phase 3 Sarcoidosis Trial
5M ago
8K
ATYR
ATYR Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsATYR Upcoming Earnings Report: What to Expect?
5M ago
ATYR
aTyr Pharma Inc options imply 14.1% move in share price post-earnings
Premium
The Fly
aTyr Pharma Inc options imply 14.1% move in share price post-earnings
5M ago
ATYR
Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation
Premium
Company Announcements
Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation
7M ago
ATYR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >